Safety and efficacy of the LAP-BAND AP® adjustable gastric band in the treatment of obesity: Results at 2 years

Postgraduate Medicine

Volumn 124, Issue 4, 2012, Pages 181-188

  Shayani, Vafa ^a   Voellinger, David ^b   Liu, Carson ^c   Cornell, Christopher ^d   Okerson, Ted ^d,e  

^a Bariatric Institute of Greater Chicago   (United States)

^b Southeast Bariatrics   (United States)

^c Kite Pharma   (United States)

^d ALLERGAN INC   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bariatric surgery; Comorbid condition; LAP BAND; Obesity; Quality of life; Weight loss

Indexed keywords

ADULT; ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL OBSERVATION; CLINICAL TRIAL; COMORBIDITY; DEPRESSION; FEMALE; GASTRIC BAND; GASTRIC BANDING; GASTROESOPHAGEAL REFLUX; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE; MORBID OBESITY; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY AND WEIGHT-LOSS QUALITY OF LIFE QUESTIONNAIRE; OSTEOARTHRITIS; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; SAFETY; SLEEP DISORDERED BREATHING; TREATMENT RESPONSE; UNITED STATES; WEIGHT REDUCTION; GASTROPLASTY; LAPAROSCOPY; METHODOLOGY; OBESITY; TREATMENT OUTCOME;

BODY MASS INDEX; FEMALE; GASTROPLASTY; HUMANS; LAPAROSCOPY; MALE; OBESITY; OBESITY, MORBID; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME; UNITED STATES; WEIGHT LOSS;

EID: 84876563229     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.2012.07.2561     Document Type: Article

References (41)

1. World Health Organization. Preventing chronic diseases: a vital investment: WHO global report. http://www.who.int/chp/chronic_disease_report/en/. Accessed August 10, 2010.
2. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA. 2010;303(3):235-241.
3. Herpertz S, Kielmann R, Wolf AM, Langkafel M, Senf W, Hebebrand J. Does obesity surgery improve psychosocial functioning? A systematic review. Int J Obes Relat Metab Disord. 2003;27(11):1300-1314.
4. Karlsson J, Taft C, Ryden A, Sjostrom L, Sullivan M. Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study. Int J Obes (Lond). 2007;31(8):1248-1261.
5. Mannucci E, Petroni ML, Villanova N, Rotella CM, Apolone G, Marchesini G; QUOVADIS Study Group. Clinical and psychological correlates of health-related quality of life in obese patients. Health Qual Life Outcomes. 2010;8:90.
6. Biggs ML, Mukamal KJ, Luchsinger JA, et al. Association between adiposity in midlife and older age and risk of diabetes in older adults. JAMA. 2010;303(24):2504-2512.
7. Fontaine KR, Redden DT, Wang C, Westfall AO, Allison DB. Years of life lost due to obesity. JAMA. 2003;289(2):187-193.
8. Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D'Agostino RB Sr. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care. 2008;31(8):1582-1584.
9. Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM. Changes in incidence of diabetes in U.S. adults, 1997-2003. Am J Prev Med. 2006;30(5):371-377.
10. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA. 2003;289(1):76-79.
11. Clements R, Saber A, Teixeira J, Provost D, Fanelli R, Richardson W; Society of American Gastrointestinal and Endoscopic Surgeons Guidelines Committee. Guidelines for institutions granting bariatric privileges utilizing laparoscopic techniques. Society of American Gastrointestinal and Endoscopic Surgeons Guidelines Committee. Surg Endosc. 2011;25(3):671-676.
12. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery Medical Guidelines for Clinical Practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Relat Dis. 2008;4(5 suppl):S109-S184.
13. Norris SL, Zhang X, Avenell A, et al. Long-term non-pharmacologic weight loss interventions for adults with type 2 diabetes. Cochrane Database Syst Rev. 2005;(2):CD004095.
14. Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Long-term non-pharmacological weight loss interventions for adults with prediabetes. Cochrane Database Syst Rev. 2005;(2):CD005270.
15. Padwal R, Rucker D, Li SK, Lau DC. Long-term pharmacotherapy for obesity and overweight. Cochrane Database Syst Rev. 2009;(1):CD004094.
16. Siebenhofer A, Horvath K, Jeitler K, et al. Long-term effects of weight-reducing drugs in hypertensive patients. Cochrane Database Syst Rev. 2009;(3):CD007654.
17. Hutter MM, Schirmer BD, Jones DB, et al. First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass. Ann Surg. 2011;254(3):410-420; discussion 420-422.
18. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122(3):248-256.e245.
19. O'Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16(8):1032-1040.
20. Strain GW, Saif T, Gagner M, Rossidis M, Dakin G, Pomp A. Cross-sectional review of effects of laparoscopic sleeve gastrectomy at 1, 3, and 5 years. Surg Obes Relat Dis. 2011;7(6):714-719.
21. Flum DR, Belle SH, King WC, et al; Longitudinal Assessment of Bariatric Surgery (LABS) Consortium. Perioperative safety in the longitudinal assessment of bariatric surgery. N Engl J Med. 2009;361(5):445-454.
22. Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg. 2004;14(9):1157-1164.
23. Ray JB, Ray S. Safety, efficacy, and durability of laparoscopic adjustable gastric banding in a single surgeon U.S. community practice. Surg Obes Relat Dis. 2011;7(2):140-144.
24. Lap-Band [system fact sheet]. Irvine, CA: Allergan, Inc.; 2011.
25. Patrick DL, Bushnell DM, Rothman M. Performance of two self-report measures for evaluating obesity and weight loss. Obes Res. 2004;12(1):48-57.
26. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991;14(6):540-545.
27. Johns MW. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res. 2000;9(1):5-11.
28. Woodman G, Cywes R, Billy H, Montgomery K, Cornell C, Okerson T; APEX Study Group. Effect of adjustable gastric banding on changes in gastroesophageal reflux disease (GERD) and quality of life. Curr Med Res Opin. 2012;28(4):581-589.
29. Ponce J, Lindsey B, Pritchett S, Bleech M, Marlowe K. New adjustable gastric bands available in the United States: a comparative study. Surg Obes Relat Dis. 2011;7(1):74-79.
30. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74(5):579-584.
31. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346(6):393-403.
32. Magro DO, Geloneze B, Delfini R, Pareja BC, Callejas F, Pareja JC. Long-term weight regain after gastric bypass: a 5-year prospective study. Obes Surg. 2008;18(6):648-651.
33. Weichman K, Ren C, Kurian M, et al. The effectiveness of adjustable gastric banding: a retrospective 6-year U.S. follow-up study. Surg Endosc. 2011;25(2):397-403.
34. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292(14):1724-1737.
35. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323.
36. DiGiorgi M, Rosen DJ, Choi JJ, et al. Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up. Surg Obes Relat Dis. 2010;6(3):249-253.
37. Lerdal A, Andenaes R, Bjornsborg E, et al. Personal factors associated with health-related quality of life in persons with morbid obesity on treatment waiting lists in Norway. Qual Life Res. 2011;20(8):1187-1196.
38. Ahroni JH, Montgomery KF, Watkins BM. Laparoscopic adjustable gastric banding: weight loss, co-morbidities, medication usage and quality of life at one year. Obes Surg. 2005;15(5):641-647.
39. Chapman AE, Kiroff G, Game P, et al. Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic literature review. Surgery. 2004;135(3):326-351.
40. Nguyen NT, Hohmann S, Nguyen XM, Elliott C, Masoomi H. Outcome of laparoscopic adjustable gastric banding and prevalence of band revision and explantation at academic centers: 2007-2009 [published online ahead of print September 28, 2011]. Surg Obes Relat Dis.
41. O'Brien PE, Dixon JB, Laurie C, Anderson M. A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg. 2005;15(6):820-826.